Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment-Reference-Cited by-同舟云学术

Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment

Published:2005-03 Issue:3 Volume:29 Page:287-291
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Roberto Latagliata,Massimo Breccia,Ida Carmosino,Chiara Sarlo,Enrico Montefusco,Marco Mancini,Antonio Chistolini,Rosa De Cuia,Eleonora Russo,Giacomo Morano Salvatore,Francesca Biondo,Antonio Spadea,Franco Mandelli,Giuliana Alimena,Fiammetta Natalino

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Chronic myeloid leukemia: from basics to bedside;Thijsen;Leukemia,1999

2. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

3. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age specific rates of incidence and of complete remission;Brincker;Cancer Treat Rep,1985

4. A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia;Baccarani;Blood,2002

5. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia;N Engl J Med,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel;Critical Reviews in Oncology/Hematology;2017-12

2. Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase;Drugs & Aging;2016-03-09

3. Overcoming therapy failure in elderly patients with chronic myeloid leukemia;International Journal of Hematologic Oncology;2014-10

4. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV;Annals of Hematology;2013-10-27

5. Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia;International Journal of Hematology;2012-08-15